NCT06930404 Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea
| NCT ID | NCT06930404 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ResMed |
| Condition | Obstructive Sleep Apnea (OSA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2025-09-15 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2025-09-15 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will collect data on a range of signals such as facial scans, videos (including speaking, blinking and swallowing) and heart rate variability to assess whether any of these measures are useful for diagnosing obstructive sleep apnea
Eligibility Criteria
Inclusion Criteria: Adults aged \>= 18 Ability to read and comprehend English Exclusion Criteria: * Previous diagnosis of OSA * Respiratory diseases (such COPD, lung cancer, fibrosis of the lungs, lung injury) * Subjects who are or may be pregnant, breastfeeding or within 6 weeks postpartum (which may impact HRV temporarily) * Subjects with a pacemaker
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06930404 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obstructive Sleep Apnea (OSA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06930404 currently recruiting?
Yes, NCT06930404 is actively recruiting participants. Contact the research team at alison.wimms@resmed.com.au for enrollment information.
Where is the NCT06930404 trial being conducted?
This trial is being conducted at Sydney, Australia.
Who is sponsoring the NCT06930404 clinical trial?
NCT06930404 is sponsored by ResMed. The trial plans to enroll 800 participants.